Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Generation Bio Co (NASDAQ: GBIO) closed at $0.43 down -6.37% from its previous closing price of $0.46. In other words, the price has decreased by -$6.37 from its previous closing price. On the day, 0.56 million shares were traded. GBIO stock price reached its highest trading level at $0.4518 during the session, while it also had its lowest trading level at $0.4122.
Ratios:
For a deeper understanding of Generation Bio Co’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.50 and its Current Ratio is at 5.50. In the meantime, Its Debt-to-Equity ratio is 1.09 whereas as Long-Term Debt/Eq ratio is at 0.93.
On November 08, 2022, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $9.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 10 ’25 when Quinn Anthony G. bought 125,791 shares for $0.96 per share. The transaction valued at 120,759 led to the insider holds 214,286 shares of the business.
Quinn Anthony G. bought 85,000 shares of GBIO for $82,450 on Jan 13 ’25. The Director now owns 299,286 shares after completing the transaction at $0.97 per share. On Jul 01 ’24, another insider, Paone Antoinette, who serves as the CHIEF OPERATING OFFICER of the company, sold 6,719 shares for $2.74 each. As a result, the insider received 18,410 and left with 13,807 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GBIO now has a Market Capitalization of 28665980 and an Enterprise Value of -62997036. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.44 while its Price-to-Book (P/B) ratio in mrq is 0.33. Its current Enterprise Value per Revenue stands at -3.167 whereas that against EBITDA is 0.848.
Stock Price History:
The Beta on a monthly basis for GBIO is 2.74, which has changed by -0.9002331 over the last 52 weeks, in comparison to a change of 0.06429911 over the same period for the S&P500. Over the past 52 weeks, GBIO has reached a high of $4.65, while it has fallen to a 52-week low of $0.44. The 50-Day Moving Average of the stock is -34.75%, while the 200-Day Moving Average is calculated to be -76.42%.
Shares Statistics:
For the past three months, GBIO has traded an average of 507.65K shares per day and 453910 over the past ten days. A total of 66.97M shares are outstanding, with a floating share count of 45.80M. Insiders hold about 31.65% of the company’s shares, while institutions hold 63.75% stake in the company. Shares short for GBIO as of 1741910400 were 1679499 with a Short Ratio of 3.31, compared to 1739491200 on 2497036. Therefore, it implies a Short% of Shares Outstanding of 1679499 and a Short% of Float of 4.18.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
